Brain monoamine oxidase A activity predicts trait aggression. 2008

Nelly Alia-Klein, and Rita Z Goldstein, and Aarti Kriplani, and Jean Logan, and Dardo Tomasi, and Benjamin Williams, and Frank Telang, and Elena Shumay, and Anat Biegon, and Ian W Craig, and Fritz Henn, and Gene-Jack Wang, and Nora D Volkow, and Joanna S Fowler
Medical Department, Brookhaven National Laboratory, Upton, New York 11973, USA. nellyklein@bnl.gov

The genetic deletion of monoamine oxidase A (MAO A), an enzyme that breaks down the monoamine neurotransmitters norepinephrine, serotonin, and dopamine, produces aggressive phenotypes across species. Therefore, a common polymorphism in the MAO A gene (MAOA, Mendelian Inheritance in Men database number 309850, referred to as high or low based on transcription in non-neuronal cells) has been investigated in a number of externalizing behavioral and clinical phenotypes. These studies provide evidence linking the low MAOA genotype and violent behavior but only through interaction with severe environmental stressors during childhood. Here, we hypothesized that in healthy adult males the gene product of MAO A in the brain, rather than the gene per se, would be associated with regulating the concentration of brain amines involved in trait aggression. Brain MAO A activity was measured in vivo in healthy nonsmoking men with positron emission tomography using a radioligand specific for MAO A (clorgyline labeled with carbon 11). Trait aggression was measured with the multidimensional personality questionnaire (MPQ). Here we report for the first time that brain MAO A correlates inversely with the MPQ trait measure of aggression (but not with other personality traits) such that the lower the MAO A activity in cortical and subcortical brain regions, the higher the self-reported aggression (in both MAOA genotype groups) contributing to more than one-third of the variability. Because trait aggression is a measure used to predict antisocial behavior, these results underscore the relevance of MAO A as a neurochemical substrate of aberrant aggression.

UI MeSH Term Description Entries
D008297 Male Males
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D010551 Personality Behavior-response patterns that characterize the individual. Personalities
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003010 Clorgyline An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE. Clorgilin,Chlorgyline,Clorgiline
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Nelly Alia-Klein, and Rita Z Goldstein, and Aarti Kriplani, and Jean Logan, and Dardo Tomasi, and Benjamin Williams, and Frank Telang, and Elena Shumay, and Anat Biegon, and Ian W Craig, and Fritz Henn, and Gene-Jack Wang, and Nora D Volkow, and Joanna S Fowler
February 2009, Proceedings of the National Academy of Sciences of the United States of America,
Nelly Alia-Klein, and Rita Z Goldstein, and Aarti Kriplani, and Jean Logan, and Dardo Tomasi, and Benjamin Williams, and Frank Telang, and Elena Shumay, and Anat Biegon, and Ian W Craig, and Fritz Henn, and Gene-Jack Wang, and Nora D Volkow, and Joanna S Fowler
April 2015, Behavioural brain research,
Nelly Alia-Klein, and Rita Z Goldstein, and Aarti Kriplani, and Jean Logan, and Dardo Tomasi, and Benjamin Williams, and Frank Telang, and Elena Shumay, and Anat Biegon, and Ian W Craig, and Fritz Henn, and Gene-Jack Wang, and Nora D Volkow, and Joanna S Fowler
March 1967, Science (New York, N.Y.),
Nelly Alia-Klein, and Rita Z Goldstein, and Aarti Kriplani, and Jean Logan, and Dardo Tomasi, and Benjamin Williams, and Frank Telang, and Elena Shumay, and Anat Biegon, and Ian W Craig, and Fritz Henn, and Gene-Jack Wang, and Nora D Volkow, and Joanna S Fowler
June 1980, Biological psychiatry,
Nelly Alia-Klein, and Rita Z Goldstein, and Aarti Kriplani, and Jean Logan, and Dardo Tomasi, and Benjamin Williams, and Frank Telang, and Elena Shumay, and Anat Biegon, and Ian W Craig, and Fritz Henn, and Gene-Jack Wang, and Nora D Volkow, and Joanna S Fowler
August 2018, Progress in neuro-psychopharmacology & biological psychiatry,
Nelly Alia-Klein, and Rita Z Goldstein, and Aarti Kriplani, and Jean Logan, and Dardo Tomasi, and Benjamin Williams, and Frank Telang, and Elena Shumay, and Anat Biegon, and Ian W Craig, and Fritz Henn, and Gene-Jack Wang, and Nora D Volkow, and Joanna S Fowler
May 1982, Pharmacological research communications,
Nelly Alia-Klein, and Rita Z Goldstein, and Aarti Kriplani, and Jean Logan, and Dardo Tomasi, and Benjamin Williams, and Frank Telang, and Elena Shumay, and Anat Biegon, and Ian W Craig, and Fritz Henn, and Gene-Jack Wang, and Nora D Volkow, and Joanna S Fowler
June 1981, Archives of general psychiatry,
Nelly Alia-Klein, and Rita Z Goldstein, and Aarti Kriplani, and Jean Logan, and Dardo Tomasi, and Benjamin Williams, and Frank Telang, and Elena Shumay, and Anat Biegon, and Ian W Craig, and Fritz Henn, and Gene-Jack Wang, and Nora D Volkow, and Joanna S Fowler
January 1977, Progress in neurobiology,
Nelly Alia-Klein, and Rita Z Goldstein, and Aarti Kriplani, and Jean Logan, and Dardo Tomasi, and Benjamin Williams, and Frank Telang, and Elena Shumay, and Anat Biegon, and Ian W Craig, and Fritz Henn, and Gene-Jack Wang, and Nora D Volkow, and Joanna S Fowler
April 1963, Japanese journal of pharmacology,
Nelly Alia-Klein, and Rita Z Goldstein, and Aarti Kriplani, and Jean Logan, and Dardo Tomasi, and Benjamin Williams, and Frank Telang, and Elena Shumay, and Anat Biegon, and Ian W Craig, and Fritz Henn, and Gene-Jack Wang, and Nora D Volkow, and Joanna S Fowler
January 1985, Ukrainskii biokhimicheskii zhurnal (1978),
Copied contents to your clipboard!